CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma

Background: Ovarian clear cell carcinoma (OCCC) is resistant to platinum chemotherapy and is characterized by poor prognosis. Today, the use of poly (ADP-ribose) polymerase (PARP) inhibitor, which is based on synthetic lethality strategy and characterized by cancer selectivity, is widely used for ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Naoki, Yamada, Yuki, Kobayashi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198755/
https://www.ncbi.nlm.nih.gov/pubmed/34070839
http://dx.doi.org/10.3390/ijms22115869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198755/
https://www.ncbi.nlm.nih.gov/pubmed/34070839
http://dx.doi.org/10.3390/ijms22115869

Ejemplares similares